SCHEMBL2862938

SCHEMBL2862938

O=C(NC1CC1)c1cc2c(-c3cc4ccccc4s3)n[nH]c2cc1F

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK10 P53779 1/20 0.50
PIP5K1C O60331 1/20 0.48
SIRT2 Q8IXJ6 1/20 0.43
SIRT1 Q96EB6 1/20 0.43
CHEK1 O14757 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
MAPKAPK2 P49137 1/20 0.42
DCK P27707 1/20 0.42
KDR P35968 3/20 0.40
WNT1 P04628 2/20 0.40
DYRK1A Q13627 2/20 0.40
NTRK1 P04629 1/20 0.39
FLT3 P36888 1/20 0.39
NTRK3 Q16288 1/20 0.39
NTRK2 Q16620 1/20 0.39
SMYD3 Q9H7B4 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
PDGFRB P09619 1/20 0.38
KIT P10721 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2870547 0.86 RAB9A (0.48) MAPK10PIP5K1CSIRT2SIRT1CHEK1
SCHEMBL2862999 0.84 MAPK10 (0.47) MAPK10PIP5K1CSIRT2SIRT1MAPKAPK2
SCHEMBL2857326 0.83 PIP5K1C (0.48) MAPK10PIP5K1CSIRT2SIRT1CHEK1
SCHEMBL2867207 0.82 KDR (0.48) CHEK1KDRWNT1DYRK1ASMYD3
SCHEMBL4339880 0.81 RAB9A (0.48) MAPK10SIRT2SIRT1L3MBTL1NPC1
SCHEMBL4334964 0.81 RAB9A (0.48) MAPK10SIRT2SIRT1L3MBTL1NPC1
SCHEMBL4326727 0.79 TRPV3 (0.47) MAPK10PIP5K1CSIRT2SIRT1MAPKAPK2
SCHEMBL4329381 0.79 MAPK10 (0.59) MAPK10PIP5K1CSIRT2SIRT1MAPKAPK2
SCHEMBL4334072 0.78 HPGD (0.47) MAPK10NPC1RAB9A
SCHEMBL4341432 0.78 ALDH1A1 (0.47) MAPK10NTRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-6982274-B2 1H-indazole compound EISAI CO., LTD. (JP) 2006-01-03 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed
US-20040127538-A1 Novel 1h-indazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 MAPK10 29/4885PIP5K1C 1431/4885SIRT2 1519/4885
US-20040127538-A1 Novel 1h-indazole compound MAPK1, MAPK14, MAPK3 MAPK10 27/4885PIP5K1C 1252/4885SIRT2 2133/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 MAPK10 29/4885PIP5K1C 1431/4885SIRT2 1519/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.